Article

Anchoring proteins encounter mitotic kinases

Howard Hughes Medical Institute
Cell cycle (Georgetown, Tex.) (Impact Factor: 4.57). 03/2013; 12(6). DOI: 10.4161/cc.24192
Source: PubMed
Download full-text

Full-text

Available from: europepmc.org · License: CC BY-NC
  • Source
    • "Therefore, the dual effect of YTX over tumor and non-tumor cells point to this compound as a powerful antitumoral drug or at least as a good drug lead [75,76]. In this sense, AKAP 149 protein is essential for mitosis777879, hence those factors that prevent the activity of this protein cause cell death, as in the case of YTX in K-526 cells. This line of reasoning based on AKAP 149 would explain the differences in response between normal and tumor cells to YTX. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Yessotoxin (YTX) is a polyether compound produced by dinoflagellates and accumulated in filter feeding shellfish. No records about human intoxications induced by this compound have been published, however it is considered a toxin. Modifications in second messenger levels, protein levels, immune cells, cytoskeleton or activation of different cellular death types have been published as consequence of YTX exposure. This review summarizes the main intracellular pathways modulated by YTX and their pharmacological and therapeutic implications.
    Full-text · Article · Jan 2016 · Marine Drugs
  • Source
    • "These cancers can be exacerbated by mislocalization or misregulation of mitogenic and mitotic protein kinase cascades (Carnegie et al., 2009; Scott and Pawson, 2009). The A-kinase anchoring protein Gravin/AKAP12/ SSeCKS has been implicated in the control of mitotic progression (Xia et al., 2001; Gelman, 2010; Canton et al., 2012; Canton and Scott, 2013). We now report that Gravin is depleted in proliferating germ line-derived tumors from several patients diagnosed with testicular seminoma. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Correct orientation of the mitotic spindle in stem cells underlies organogenesis. Spindle abnormalities correlate with cancer progression in germ line-derived tumors. We discover a macromolecular complex between the scaffolding protein Gravin/AKAP12 and the mitotic kinases, Aurora A and Plk1, that is down regulated in human seminoma. Depletion of Gravin correlates with an increased mitotic index and disorganization of seminiferous tubules. Biochemical, super-resolution imaging, and enzymology approaches establish that this Gravin scaffold accumulates at the mother spindle pole during metaphase. Manipulating elements of the Gravin-Aurora A-Plk1 axis prompts mitotic delay and prevents appropriate assembly of astral microtubules to promote spindle misorientation. These pathological responses are conserved in seminiferous tubules from Gravin−/− mice where an overabundance of Oct3/4 positive germ line stem cells displays randomized orientation of mitotic spindles. Thus, we propose that Gravin-mediated recruitment of Aurora A and Plk1 to the mother (oldest) spindle pole contributes to the fidelity of symmetric cell division.
    Full-text · Article · Sep 2015 · eLife Sciences
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Key challenges of biopsy-based determination of prostate cancer aggressiveness include tumour heterogeneity, biopsy-sampling error, and variations in biopsy interpretation. The resulting uncertainty in risk assessment leads to significant overtreatment, with associated costs and morbidity. We developed a performance-based strategy to identify protein biomarkers predictive of prostate cancer aggressiveness and lethality regardless of biopsy-sampling variation. Methods: Prostatectomy samples from a large patient cohort with long follow-up were blindly assessed by expert pathologists who identified the tissue regions with the highest and lowest Gleason grade from each patient. To simulate biopsy-sampling error, a core from a high- and a low-Gleason area from each patient sample was used to generate a 'high' and a 'low' tumour microarray, respectively. Results: Using a quantitative proteomics approach, we identified from 160 candidates 12 biomarkers that predicted prostate cancer aggressiveness (surgical Gleason and TNM stage) and lethal outcome robustly in both high- and low-Gleason areas. Conversely, a previously reported lethal outcome-predictive marker signature for prostatectomy tissue was unable to perform under circumstances of maximal sampling error. Conclusions: Our results have important implications for cancer biomarker discovery in general and development of a sampling error-resistant clinical biopsy test for prediction of prostate cancer aggressiveness.
    Full-text · Article · Jul 2014 · British Journal of Cancer
Show more